相似文献
1
Dapagliflozin: BMS 512148; BMS-512148.
Drugs R D. 2010;10(1):47-54. doi: 10.2165/11537740-000000000-00000.
2
Dapagliflozin, an oral sodium glucose cotransporter type 2 inhibitor for the treatment of type 2 diabetes mellitus.
IDrugs. 2009 Dec;12(12):785-98.
3
Dapagliflozin, an SGLT2 inhibitor for the treatment of type 2 diabetes.
Drugs Today (Barc). 2013 May;49(5):289-301. doi: 10.1358/dot.2013.49.5.1964714.
4
Dapagliflozin for the treatment of type 2 diabetes.
Ann Pharmacother. 2012 Apr;46(4):590-8. doi: 10.1345/aph.1Q538. Epub 2012 Mar 20.
5
Molecule of the month. Dapagliflozin.
Drug News Perspect. 2007 Dec;20(10):645.
6
[Sodium-glucose co-transporter-2 inhibitors: from the bark of apple trees and familial renal glycosuria to the treatment of type 2 diabetes mellitus].
Med Clin (Barc). 2013 Sep;141 Suppl 2:31-5. doi: 10.1016/S0025-7753(13)70061-7.
7
SGLT2 inhibition with dapagliflozin -- a novel approach for the management of type 2 diabetes.
Aust Fam Physician. 2013 Oct;42(10):706-10.
8
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus.
Expert Rev Clin Pharmacol. 2017 Jul;10(7):763-772. doi: 10.1080/17512433.2017.1322507. Epub 2017 May 2.
9
Dapagliflozin: a new sodium-glucose cotransporter 2 inhibitor for treatment of type 2 diabetes.
Am J Health Syst Pharm. 2015 Mar 1;72(5):361-72. doi: 10.2146/ajhp140168.
10
A paradigm shift in diabetes therapy--dapagliflozin and other SGLT2 inhibitors.
Discov Med. 2011 Mar;11(58):255-63.
引用本文的文献
1
Assessment of basic pharmacokinetic parameters of dapagliflozin in TTS formulations in male minipigs.
Sci Rep. 2024 Oct 8;14(1):23504. doi: 10.1038/s41598-024-74675-z.
2
Common UGT1A9 polymorphisms do not have a clinically meaningful impact on the apparent oral clearance of dapagliflozin in type 2 diabetes mellitus.
Br J Clin Pharmacol. 2022 Feb;88(4):1942-1946. doi: 10.1111/bcp.15117. Epub 2022 Jan 23.
本文引用的文献
1
Abstracts of the 43rd European Association for the Study of Diabetes (EASD) annual meeting, 18-21 September 2007, Amsterdam, The Netherlands.
Diabetologia. 2007 Sep;50 Suppl 1:S7-515. doi: 10.1007/s00125-007-0809-7.
Zotero 插件
